Skip to main content
. Author manuscript; available in PMC: 2019 Feb 1.
Published in final edited form as: Eur J Immunol. 2017 Dec 15;48(2):293–305. doi: 10.1002/eji.201747184

Table 1.

Characteristics of subjects enrolled in the study

Variable HD LTBI TB TB-HIV Total
Total subjects, n 26 14 24 5 69
Age (range) a) 34–60 22–38 28–40
Clinical characteristics a) No disease, Pulmonary TB (22)Miliary TB (1) Miliary TB and
Mantoux positive Extra-pulmonary TB (1) HIV co-infection
Miliary TB (1)
Nationality b) Italian Italian (6) Italian (2)
North African (18) North African (3)
Subjects used for ex vivo analysis, n 26/26 14/14 24/24 5/5 69
Subjects included in ex vivo analysis of memory compartment (TM+ events count >100) 16/26 11/14 20/24 5/5 52
Subjects used for expansion with PHA and HLA-E peptides 26/26 12/14 17/24 4/5 60
Subjects included in functional analysis upon expansion (TM+ events count >1000) 14/26 6/13 15/17 panel A
14/17 panel B
- 35
Subjects used for expansion with PHA and HLA-A2 peptides 3/26 3/13 7/17 panel A - 13
6/17 panel B 12
Subjects used for TCR Vβ16 analysis 6/26 7/13 8/17 - 21
a)

No information of the anonymous samples was available.

b)

13 samples were obtained from anonymous bloodbank donors (Sanquin Bloodbank, the Netherlands); 13 samples were collected from the Dipartimento di Medicina Clinica e delle Patologie Emergenti, University Hospital, Palermo.

HD, Healthy Donor; LTBI, Latently TB Infected subjects; TB, active TB patients TB-HIV, TB-HIV co-infected patients.